SCHEMBL20133698

SCHEMBL20133698

Cc1cc(C)c(C(=O)O)cc1NC1CCN(c2cccc(Cl)c2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
HTT P42858 3/20 0.48
TSHR P16473 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
NPSR1 Q6W5P4 1/20 0.48
NOTUM Q6P988 1/20 0.47
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
MAPT P10636 2/20 0.45
NPY5R Q15761 1/20 0.45
HTR1A P08908 1/20 0.44
HTR2A P28223 1/20 0.44
HTR7 P34969 1/20 0.44
HTR6 P50406 1/20 0.44
LMNA P02545 1/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA9 Q16790 1/20 0.43
MAPK1 P28482 1/20 0.43
RPS6KB1 P23443 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20141082 0.90 MTOR (0.45) ALDH1A1TSHRSMN1; SMN2MEN1KMT2A
SCHEMBL20133697 0.89 KDM4E (0.52) ALDH1A1HTTTSHRSMN1; SMN2NPSR1
SCHEMBL20133837 0.87 MTNR1A (0.49) ALDH1A1SMN1; SMN2NOTUMMEN1KMT2A
SCHEMBL20133680 0.85 NOTUM (0.51) NOTUMNPY5RRPS6KB1
SCHEMBL20133703 0.83 MTOR (0.49) ALDH1A1SMN1; SMN2NOTUMMEN1KMT2A
SCHEMBL20133691 0.80 MTOR (0.69) ALDH1A1HTTTSHRSMN1; SMN2NPSR1
SCHEMBL20141600 0.80 MAPT (0.49) ALDH1A1TSHRSMN1; SMN2MEN1KMT2A
SCHEMBL20141134 0.78 MTNR1A (0.49) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL20133811 0.77 MTOR (0.41) ALDH1A1TSHRSMN1; SMN2MEN1KMT2A
SCHEMBL20149887 0.77 MTOR (0.47) RPS6KB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2020-11-24 US disclosed
US-20200207716-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. 2020-07-02 US disclosed
US-10414727-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2019-09-17 US disclosed
WO-2018089499-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed
US-20180127370-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR ALDH1A1 3942/4885HTT 383/4885TSHR 4664/4885
US-10414727-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR ALDH1A1 3942/4885HTT 383/4885TSHR 4664/4885
US-20180127370-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF MTOR, RICTOR, RPTOR ALDH1A1 3942/4885HTT 383/4885TSHR 4664/4885
US-20200207716-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF MTOR, RICTOR, RPTOR ALDH1A1 3942/4885HTT 383/4885TSHR 4664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.